ArticleScientific reports2025
Mendelian randomization analysis of the association between vitamin B12 deficiency anaemia and the risk of developing lung disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The causal relationship between vitamin B12 deficiency anaemia and the risk of developing lung diseases remains unclear. This study aimed to clarify that relationship using Mendelian randomization (MR) with Bayesian weighting, focusing on pulmonary fibrosis (PF), idiopathic PF (IPF), eosinophilic asthma (EA), squamous cell lung cancer (LUSC), chronic obstructive pulmonary disease (COPD), and pulmonary embolism (PE). We analysed genome-wide association study (GWAS) data, applied five MR models with Bayesian methods to assess causality, and validated the results via sensitivity analysis. The MVMR method explores whether vitamin B12-deficient anaemia affects the pathogenesis of IPF independently of BMI. SMR was used to explore IPF-related pathogenesis, whereas a meta-analysis was used to consolidate LUSC MR findings across ethnicities. IVW analysis revealed a positive causal link between vitamin B12 deficiency anaemia status and the risk of developing PF [OR (95% CI) = 1.161 (1.021, 1.319), P = 0.023], IPF [OR (95% CI) = 1.176 (1.002, 1.380), P = 0.047 (Bayesian MR)] and EA [OR (95% CI) = 1.394 (1.084, 1.793), P = 0.010]. The results of the study demonstrate that the development of IPF is influenced by vitamin B12 deficiency independently of BMI. Conversely, vitamin B12 deficiency anaemia status was negatively associated with the development of LUSC [OR (95% CI) = 0.879 (0.760, 0.995), P = 0.001], and no causal association was detected between vitamin B12 deficiency anaemia status and the development of COPD or PE. The reverse MR analysis yielded nonsignificant results. The SMR analysis revealed a significant association between IPF onset and CUBN, a vitamin B12 target. Post-MR meta-analysis confirmed the credibility and homogeneity of these findings. Vitamin B12 deficiency anaemia is causally associated with the development of PF, IPF, and EA but is negatively associated with the development of LUSC. No causality was observed for COPD or PE. Notably, CUBN emerged as a key IPF-related gene, highlighting the intricate relationship between vitamin B12 status and pulmonary health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.